126 related articles for article (PubMed ID: 15193436)
21. Structural analysis of the 17q22-23 amplicon identifies several independent targets of amplification in breast cancer cell lines and tumors.
Wu G; Sinclair C; Hinson S; Ingle JN; Roche PC; Couch FJ
Cancer Res; 2001 Jul; 61(13):4951-5. PubMed ID: 11431322
[TBL] [Abstract][Full Text] [Related]
22. Profiling of chemonaive osteosarcoma and paired-normal cells identifies EBF2 as a mediator of osteoprotegerin inhibition to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
Patiño-García A; Zalacain M; Folio C; Zandueta C; Sierrasesúmaga L; San Julián M; Toledo G; De Las Rivas J; Lecanda F
Clin Cancer Res; 2009 Aug; 15(16):5082-91. PubMed ID: 19671856
[TBL] [Abstract][Full Text] [Related]
23. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation.
Henriksen J; Aagesen TH; Maelandsmo GM; Lothe RA; Myklebost O; Forus A
Oncogene; 2003 Aug; 22(34):5358-61. PubMed ID: 12917637
[TBL] [Abstract][Full Text] [Related]
24. Quantitative analysis of promoter hypermethylation in multiple genes in osteosarcoma.
Hou P; Ji M; Yang B; Chen Z; Qiu J; Shi X; Lu Z
Cancer; 2006 Apr; 106(7):1602-9. PubMed ID: 16502411
[TBL] [Abstract][Full Text] [Related]
25. Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma.
Lee WI; Bacchni P; Bertoni F; Maeng YH; Park YK
Oncol Rep; 2004 Jul; 12(1):125-8. PubMed ID: 15201972
[TBL] [Abstract][Full Text] [Related]
26. Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes.
Bourdon V; Naef F; Rao PH; Reuter V; Mok SC; Bosl GJ; Koul S; Murty VV; Kucherlapati RS; Chaganti RS
Cancer Res; 2002 Nov; 62(21):6218-23. PubMed ID: 12414650
[TBL] [Abstract][Full Text] [Related]
27. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetic considerations in osteosarcoma.
Hansen MF
Clin Orthop Relat Res; 1991 Sep; (270):237-46. PubMed ID: 1679382
[TBL] [Abstract][Full Text] [Related]
29. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
30. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors.
Toma CD; Svoboda M; Arrich F; Ekmekcioglu C; Assadian O; Thalhammer T
J Pineal Res; 2007 Sep; 43(2):206-13. PubMed ID: 17645699
[TBL] [Abstract][Full Text] [Related]
31. Genomic signatures of chromosomal instability and osteosarcoma progression detected by high resolution array CGH and interphase FISH.
Selvarajah S; Yoshimoto M; Ludkovski O; Park PC; Bayani J; Thorner P; Maire G; Squire JA; Zielenska M
Cytogenet Genome Res; 2008; 122(1):5-15. PubMed ID: 18931480
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of a KIT-positive and stem cell factor-producing cell line, KTHOS, derived from human osteosarcoma.
Hitora T; Yamamoto T; Akisue T; Marui T; Nakatani T; Kawamoto T; Nagira K; Yoshiya S; Kurosaka M
Pathol Int; 2005 Feb; 55(2):41-7. PubMed ID: 15693848
[TBL] [Abstract][Full Text] [Related]
33. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.
Kao J; Pollack JR
Genes Chromosomes Cancer; 2006 Aug; 45(8):761-9. PubMed ID: 16708353
[TBL] [Abstract][Full Text] [Related]
34. [Comparative genomic hybridization (CGH) for detecting a heretofore undescribed amplified chromosomal segment in high-grade medullary osteosarcoma].
Brinkschmidt C; Blasius S; Bürger H; Simon R; Diallo R; Battmann A; Winkelmann W; Böcker W; Dockhorn-Dworniczak B
Verh Dtsch Ges Pathol; 1998; 82():184-8. PubMed ID: 10095431
[TBL] [Abstract][Full Text] [Related]
35. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis.
Haydon RC; Luu HH; He TC
Clin Orthop Relat Res; 2007 Jan; 454():237-46. PubMed ID: 17075380
[TBL] [Abstract][Full Text] [Related]
36. Molecular dissection of 17q12 amplicon in upper gastrointestinal adenocarcinomas.
Maqani N; Belkhiri A; Moskaluk C; Knuutila S; Dar AA; El-Rifai W
Mol Cancer Res; 2006 Jul; 4(7):449-55. PubMed ID: 16849520
[TBL] [Abstract][Full Text] [Related]
37. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63.
Lim G; Karaskova J; Vukovic B; Bayani J; Beheshti B; Bernardini M; Squire JA; Zielenska M
Cancer Genet Cytogenet; 2004 Sep; 153(2):158-64. PubMed ID: 15350306
[TBL] [Abstract][Full Text] [Related]
38. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
39. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
[TBL] [Abstract][Full Text] [Related]
40. Isolation of osteosarcoma-associated amplified DNA sequences using representational difference analysis.
Simons A; Janssen IM; Suijkerbuijk RF; Veth RP; Pruszczynski M; Hulsbergen-van de Kaa CA; du Manoir S; Geurts van Kessel A
Genes Chromosomes Cancer; 1997 Oct; 20(2):196-200. PubMed ID: 9331570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
